The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Regulatory News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
28th Sep 20224:35 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSContravention of the TGA Advertising Code
23rd Sep 20227:00 amRNSUS$550,000 funding received under Mercer Facility
21st Sep 20227:00 amRNSCimetrA™ Dose Finding Study Interim Results
8th Sep 202212:47 pmRNSWebsite / Social Media update
6th Sep 202211:30 amRNSDispatch of General Meeting Documents
1st Sep 20227:00 amRNSPreliminary Financial Report for 30 June 2022
25th Aug 20227:00 amRNSFinal Payment for Malta GMP Manufacturing Plant
17th Aug 20227:00 amRNSAMC Holdings, Inc. places US$1M ArtemiC™ order
15th Aug 20227:00 amRNSCannEpil® Clinical Study on Driving Performance
11th Aug 202211:05 amRNSSecond Price Monitoring Extn
11th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 202210:30 amRNSUpdated Investor Presentation
3rd Aug 20227:00 amRNSFirst Tranche of Mercer Street Funding Received
29th Jul 20227:00 amRNSUS$10m Financing Agreement with Mercer Street
28th Jul 20227:45 amRNSPurchase of Strategic 40% Stake in AI Software
25th Jul 20227:00 amRNSJune Quarterly Activities Report and Cash Flow
19th Jul 20227:00 amRNSChief Commercial Officer Appointment
14th Jul 20224:41 pmRNSSecond Price Monitoring Extn
14th Jul 20224:36 pmRNSPrice Monitoring Extension
14th Jul 20222:05 pmRNSSecond Price Monitoring Extn
14th Jul 20222:00 pmRNSPrice Monitoring Extension
14th Jul 202211:05 amRNSSecond Price Monitoring Extn
14th Jul 202211:00 amRNSPrice Monitoring Extension
14th Jul 20229:05 amRNSSecond Price Monitoring Extn
14th Jul 20229:00 amRNSPrice Monitoring Extension
14th Jul 20227:16 amRNSClinical Study results - patients with Long COVID
8th Jul 20227:00 amRNSApproval Granted for CimetrA Dose Finding Study
6th Jul 20228:00 amRNSLaunch of ZAM - Medical data App
27th Jun 20227:00 amRNSCimetrATM Pre-clinical Trial Progress Report
24th Jun 20227:00 amRNSUSA Market Update: CimetrA Clinical Trial Progress
16th Jun 20227:00 amRNSSuccessful Glioblastoma Pre-clinical Trial Results
6th Jun 20227:00 amRNSCogniCann© Phase II Clinical Trial Results
27th May 20221:08 pmRNSCompliance Filing of UK subsidiary FY21 Accounts
23rd May 202210:43 amRNSApplication for Admission to Trading
20th May 20227:00 amRNSAcademic Paper on Effect of ArtemiC™ Published
18th May 202212:06 pmRNSDirector/PDMR Shareholding
10th May 20227:01 amRNSCannEpil® Drug Delivery System Patent Approval
9th May 202212:28 pmRNSDirector/PDMR Shareholding
6th May 20223:08 pmRNSReplacement: Director/PDMR Shareholding
5th May 202211:10 amRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSPartnership with HempStreet
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:35 pmRNSPrice Monitoring Extension
29th Apr 202210:03 amRNSMarch Quarterly Activities Report and Cash Flow
26th Apr 20227:00 amRNSAppointment of new Chief Financial Officer
25th Apr 202211:08 amRNSApplication for Admission to Trading
21st Apr 20227:00 amRNSCimetrA™ Patent Approved by European IP Office
12th Apr 20228:36 amRNSPerformance Rights and Change of CFO
7th Apr 202210:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.